(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

HCID 55891CAS 1217600-34-4

Grundinformationen

Standard-SMILES
CCC(=O)OC(OP(=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)C(C)C
InChIKey
BIDNLKIUORFRQP-FKDWWROVSA-N
Summenformel
C30H46NO7P
Durchschnittliche Molmasse
563,7 g/mol
Monoisotopische Masse
563,30118944

Überblick

Fosinopril is a phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor, an antihypertensive agent and a prodrug. It is a phosphinic ester and a L-proline derivative. It is functionally related to a fosinoprilat. It is a conjugate acid of a fosinopril(1-).

Namen und Bezeichner

Bevorzugter Name
(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
IUPAC
(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
Englischer Name
BIDNLKIUORFRQP-FKDWWROVSA-N
Summenformel
C30H46NO7P
Molmasse
563.66

Namen und Synonyme

Fosinopril impurity C474519-28-3(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid(2S,4S)-4-cyclohexyl-1-(2-{[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylic acid(4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)-L-prolineSR-05000001490FOSINOPRIL EP IMPURITY Cstarbld00179348B3FLG23GNSCHEMBL156261217600-34-4CHEMBL3306578
Weitere Namen anzeigen
Fosinopril Sodium Impurity 3(Fosinopril Sodium EP Impurity C)D-Proline, 4-cyclohexyl-1-[2-[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetyl]-, (4R)-rel-
BIDNLKIUORFRQP-FKDWWROVSA-NHMS2089P08HMS3715N21EBC-12085AKOS015961605AC-8775CCG-221190Rel-(2S,4S)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylic acid

Datenbank-Bezeichner

CAS
1217600-34-4、98048-97-6
PubChem CID
55891
DTXSID
DTXSID1023079
ChEMBL
CHEMBL3306578
ChEBI
CHEBI:5163
UNII
8B3FLG23GN
EC Number
112-428-6

Eigenschaften

Berechnete Struktureigenschaften

XLogP
6,2
Polarare Oberfläche (TPSA)
110 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
7
Frei drehbare Bindungen
15
Schwere Atome
39

Experimentelle und physikochemische Eigenschaften

LogP6.3
Solubility1.01e-03 g/L
Melting Point149 - 153 °C
Physical DescriptionSolid

Physikochemische Eigenschaften

Siedepunkt
705.7 · 705.7±70.0 °C(Predicted)
Dichte
1.173 · 1.173±0.06 g/cm3(Predicted)
pka
3.38 · 3.38±0.40(Predicted)

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

P203, P264+P265, P280, P305+P351+P338, P318, P337+P317, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Gefahrenhinweise

Hazard Classes and CategoriesEye Irrit. 2 (100%)

Chemie und Industrie

Pharmakologische Informationen

ATC CodeC09AA09
Cellular LocationsExtracellular
Metabolite PathwaysFosinopril Action Pathway

Anbieter5 Anbieter

广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
孟成科技(上海)有限公司400-820-6829 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
BOC Sciences16314854226 · [email protected]
湖北扬信医药科技有限公司07143299675 13092790750 · [email protected]

Zugehörige Reaktionen

0

Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.

Verknüpfte Notizen

Wird geladen…